243 related articles for article (PubMed ID: 19763117)
1. The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases.
Romero K; de Mars M; Frank D; Anthony M; Neville J; Kirby L; Smith K; Woosley RL
Clin Pharmacol Ther; 2009 Oct; 86(4):365-7. PubMed ID: 19763117
[TBL] [Abstract][Full Text] [Related]
2. Maximizing the Alzheimer's Disease Neuroimaging Initiative II.
Carrillo MC; Sanders CA; Katz RG
Alzheimers Dement; 2009 May; 5(3):271-5. PubMed ID: 19362888
[TBL] [Abstract][Full Text] [Related]
3. Partnership between academia and industry for drug discovery in Alzheimer's disease.
Ivinson AJ; Lane R; May PC; Hosford DA; Carrillo MC; Siemers ER
Alzheimers Dement; 2008 Mar; 4(2):80-8. PubMed ID: 18631952
[TBL] [Abstract][Full Text] [Related]
4. FDA user fee may speed approval of Alzheimer's, Parkinson's drugs.
Geriatrics; 1992 Dec; 47(12):15-6. PubMed ID: 1446840
[No Abstract] [Full Text] [Related]
5. Oxymoron no more: the potential of nonprofit drug companies to deliver on the promise of medicines for the developing world.
Hale VG; Woo K; Lipton HL
Health Aff (Millwood); 2005; 24(4):1057-63. PubMed ID: 16012146
[TBL] [Abstract][Full Text] [Related]
6. [Alzheimer's Disease Cooperative Study (ADCS)].
Mori H; Ikeuchi T
Brain Nerve; 2014 Jun; 66(6):691-8. PubMed ID: 24899351
[TBL] [Abstract][Full Text] [Related]
7. The olfactory vector hypothesis of neurodegenerative disease: is it viable?
Doty RL
Ann Neurol; 2008 Jan; 63(1):7-15. PubMed ID: 18232016
[TBL] [Abstract][Full Text] [Related]
8. Common Alzheimer's Disease Research Ontology: National Institute on Aging and Alzheimer's Association collaborative project.
Refolo LM; Snyder H; Liggins C; Ryan L; Silverberg N; Petanceska S; Carrillo MC
Alzheimers Dement; 2012 Jul; 8(4):372-5. PubMed ID: 22748941
[TBL] [Abstract][Full Text] [Related]
9. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
Doody RS
Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
[TBL] [Abstract][Full Text] [Related]
10. [Sense of smell, physiological ageing and neurodegenerative diseases: II. Ageing and neurodegenerative diseases].
Fusari A; Molina JA
Rev Neurol; 2009 Oct 1-15; 49(7):363-9. PubMed ID: 19774531
[TBL] [Abstract][Full Text] [Related]
11. AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease.
Lovestone S; Francis P; Kloszewska I; Mecocci P; Simmons A; Soininen H; Spenger C; Tsolaki M; Vellas B; Wahlund LO; Ward M;
Ann N Y Acad Sci; 2009 Oct; 1180():36-46. PubMed ID: 19906259
[TBL] [Abstract][Full Text] [Related]
12. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke.
Fillit H; Nash DT; Shineman D
Alzheimers Dement; 2009 Mar; 5(2):149-53. PubMed ID: 19328448
[No Abstract] [Full Text] [Related]
13. Progress in public-private partnerships to fight neglected diseases.
Gustavsen K; Hanson C
Health Aff (Millwood); 2009; 28(6):1745-9. PubMed ID: 19887415
[TBL] [Abstract][Full Text] [Related]
14. Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
Liu E; Luthman J; Cedarbaum JM; Schmidt ME; Cole PE; Hendrix J; Carrillo MC; Jones-Davis D; Tarver E; Novak G; De Santi S; Soares HD; Potter WZ; Siemers E; Schwarz AJ
Alzheimers Dement; 2015 Jul; 11(7):840-9. PubMed ID: 26194317
[TBL] [Abstract][Full Text] [Related]
15. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging.
Petanceska S; Ryan L; Silverberg N; Buckholtz N
Alzheimers Dement; 2009 Mar; 5(2):130-2. PubMed ID: 19328442
[No Abstract] [Full Text] [Related]
16. NIH coalition to speed disease target validation.
J Nucl Med; 2014 Apr; 55(4):11N. PubMed ID: 24692276
[No Abstract] [Full Text] [Related]
17. Alzheimer's disease drug development and testing at the National Institute on Aging.
Buckholtz NS
Psychopharmacol Bull; 1994; 30(1):15-7. PubMed ID: 7972623
[No Abstract] [Full Text] [Related]
18. New pathway for qualification of novel methodologies in the European Medicines Agency.
Manolis E; Vamvakas S; Isaac M
Proteomics Clin Appl; 2011 Jun; 5(5-6):248-55. PubMed ID: 21538915
[TBL] [Abstract][Full Text] [Related]
19. NINDS boosts research for biomarkers in Parkinson's disease.
Lancet Neurol; 2013 Mar; 12(3):217. PubMed ID: 23415560
[No Abstract] [Full Text] [Related]
20. The impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?
Jones-Davis DM; Buckholtz N
Alzheimers Dement; 2015 Jul; 11(7):860-4. PubMed ID: 26194319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
